NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
Clinical trial NCT03107988 · COMPLETED
Trial details
- NCT number
- NCT03107988
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2024-08-22
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.